Transparency of economic evaluations of health technologies

PharmacoEconomics

Volumn 26, Issue 3, 2008, Pages 181-183

  Rovira, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Decision making; Pharmacoeconomics

Indexed keywords

ECONOMIC ASPECT; ECONOMIC EVALUATION; EDITORIAL; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; PATIENT; PEER REVIEW; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION;

EID: 39449097300     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200826030-00002     Document Type: Editorial

References (14)

1. Drummond MF. Economic evaluation of pharmaceuticals: science or marketing? Pharmacoeconomics 1992; 1: 8-13
2. Antoñanzas F, Figueras M, Rovira J. Analysing the role of economic evaluation on decision-making in the health care system in Spain: a focus group approach. In: Gran von der Schulenburg JM, editor. The influence of economic evaluation studies on health care decision making. Amsterdam: IOS Press, 2000
3. Jacobs P, Bachynsky J, Baladi JF. A comparative review of pharmacoeconomic guidelines. Pharmacoeconomics 1995; 8: 182-9
4. Reinhardt UE. Making economic evaluations respectable. Soc Sci Med 1997; 45: 555-62
5. Hillman AL, Eisenberg JM, Pauly MV, et al. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med 1991; 324: 1362-5
6. Task force on principles for economic analysis of economic analysis of health care technology: a report on principles. Ann Intern Med 1995; 123: 61-70
7. Kassirer JP, Angell M. The journal's policy on cost-effectiveness analysis. N Engl J Med 1994; 331: 669-70
8. Barbieri M, Drummond MF. Conflict of interest in industry-sponsored economic evaluations: real or imagined? Curr Oncol Rep 2001; 3: 410-3
9. Sacristán JA, Bolaños E, Hernández JM, et al. Publication bias in health economics. Pharmacoeconomics 1997; 11: 289-91
10. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313 (7052): 275-83
11. Jefferson T, Smith R, Yee Y, et al. Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and the Lancet. JAMA 1998; 280: 275-7
12. De Angelis C, Drazen JM, Frizelle FA, et al. International Committee of Medical Journal Editors. Editorial clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004; 351: 1250-1
13. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005; 2 (5): e138
14. Martinson BC, Anderson MS, De Vries R. Scientists behaving badly. Nature 2005; 435: 737-8